抗組織蛋白□ B 市場：按產品類型、按應用、按技術、按最終用戶、按地區 - 規模、份額、展望、機會分析，2023-2030 年

預計到 2023 年，全球抗組織蛋白□ B 市場將達到 1.87 億美元，預測期內（2023-2030 年）複合年增長率為 3.2%。

組織蛋白□ B 是一種半胱氨酸蛋白□，主要存在於正常細胞的溶□體中，但在許多轉化細胞的質膜上分泌或與之相關。組織蛋白□ B 存在於所有動物和其他生物體中，在細胞蛋白質代謝中發揮重要作用。組織蛋白□家族包括絲胺酸蛋白□、天門冬胺酸蛋白□和半胱胺酸蛋白□。天門冬胺酸蛋白□類由組織蛋白□D和E組成，半胱氨酸蛋白□類由組織蛋白□B、L、H、K、S和O組成。目前，還沒有批准的組織蛋白□抑制劑上市銷售，但正在研究開發新的組織蛋白□抑制劑，用於治療癌症、創傷性腦損傷和伊波拉感染等多種疾病。抗組織蛋白□ B 抗體主要用於治療癌症、腦外傷、伊波拉感染和不孕症等疾病，目前正在研究作為 SARS-CoV-2 的治療方法。組織蛋白□ B 是一種蛋白□，有助於細胞外基質重塑，從而促進傷口癒合過程中角質形成細胞的遷移。

市場動態

主要市場參與者不斷增加的治療方法、合併和收購預計將推動全球抗組織蛋白□ B 市場的成長。例如，2020年3月31日，國家生物技術資訊中心發表了一篇文章，描述組織蛋白□B（CTSB）是一種豐富的半胱氨酸蛋白□，在內溶□體區室和細胞外區域均發揮作用。許多臨床前和臨床研究表明CTSB與許多人類疾病有關。CTSB表現量和活性與疾病進展和嚴重程度有顯著相關。目前的CTSB抑制劑缺乏足夠的特異性和藥理活性。研究人員利用基於結構的理性設計開發並生產了一種針對人類 CTSB 的人源化抗體抑制劑。

本研究的主要特點

• 本報告詳細分析了全球抗組織蛋白□B市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和複合年增長率（CAGR%）。
• 它還強調了各個細分市場的潛在收入成長機會，並為該市場提供了一系列有吸引力的投資建議。
• 它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
• 根據公司亮點、產品組合、主要亮點、績效和策略等參數對全球抗組織蛋白□ B 市場的主要參與者進行了分析。
• 本研究涵蓋的主要公司包括Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
• 該報告的見解使行銷人員和公司高管能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• 全球抗組織蛋白□ B 市場報告迎合了該行業的各個利益相關者，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
• 透過用於分析全球抗組織蛋白□ B 市場的各種策略矩陣，將有助於利害關係人做出決策。

目錄

第一章 研究目的與前提

• 研究目標
• 先決條件
• 縮略語

第二章 市場概況

• 報告摘要
  • 市場定義和範圍
• 執行摘要
• 連貫的機會地圖 (COM)

第三章 市場動態、法規與趨勢分析

• 市場動態
  • 促進者
  • 抑製劑
  • 市場機會
• 影響分析
• 近期產品發布
• 流行病學
• 合併、收購、聯盟
• 監管場景
• 重大發展
• PEST分析

第四章抗組織蛋白□ B 全球市場：COVID-19 的影響分析

• 經濟影響
• COVID-19 的流行病學
• 對供需的影響

第五章抗組織蛋白□ B 全球市場：依產品類型，2018-2030 年

• 一抗
• 蛋白質和□
• 裂解物

第六章 抗組織蛋白□ B 全球市場：依應用分類，2018-2030 年

• 癌症
• 創傷性腦損傷
• 伊波拉出血熱感染
• 不孕症治療
• 其他

第 7 章 抗組織蛋白□ B 的全球市場：依方法劃分，2018-2030 年

• 免疫組織化學 (IHC)
• 免疫螢光
• 免疫印跡
• ELISA法
• 流式細胞儀
• 其他

第 8 章全球抗組織蛋白□ B 市場：按最終用戶劃分，2018-2030 年

• 製藥公司
• 學術/研究機構

第9章抗組織蛋白□B全球市場：依地區劃分，2018-2030年

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 亞太其他地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東
• 非洲
• 北非
• 中部非洲
• 南非

第10章競爭格局

• Merck KGaA
• Bio-Techne
• BioVision Inc
• Santa Cruz Biotechnology, Inc
• MedChemExpress
• BioCat GmbH
• ApexBio Technology
• Cayman Chemical
• Selleck Chemicals
• BOC Sciences
• AG Scientific
• Virobay Inc
• Abcam Plc

第11章 章節

• 調查方法
• 關於出版商

The Global Anti-Cathepsin B Market is estimated to be valued at US$ 187.0 Million in 2023 and is expected to exhibit a CAGR of 3.2% during the forecast period (2023-2030).

Cathepsin B is a cysteine protease found mainly in the lysosomes of normal cells but is secreted or associated with the plasma membrane of many transformed cells. It is found in all animals and other organisms and plays a key role in cellular protein metabolism. The cathepsin family includes serine proteases, aspartic proteases, and cysteine proteases. The aspartyl protease class consists of cathepsins D and E. The cysteine protease class consists of cathepsins B, L, H, K, S, and O. Currently, there are no approved cathepsin inhibitors on the market, but research is ongoing to develop new cathepsin inhibitors for the treatment of various diseases such as cancer, traumatic brain injury, Ebola infection, and others. Anti-Cathespin B antibodies are majorly used for the treatment of disease conditions such as cancer, traumatic brain injury, Ebola infection, and fertility problems, and are currently under research for the treatment of SARS-CoV-2. Cathepsin B is a protease that contributes to the remodeling of the extracellular matrix and thereby promotes keratinocyte migration during wound healing.

Market Dynamics

Increasing practices of treatments, mergers, and acquisitions by key market players are expected to drive the global anti-cathepsin B market growth. For instance, on March 31, 2020, National Center for Biotechnology Information published an article explaining Cathepsin B (CTSB) is an abundant cysteine protease that functions in both endolysosomal compartments and extracellular regions. Many preclinical and clinical studies indicate that CTSB is involved in many human diseases. CTSB expression levels and activity are significantly correlated with disease progression and severity. Current CTSB inhibitors lack sufficient specificity and pharmacological activity. Using structure-based rational design, researchers developed and produced a humanized antibody inhibitor targeting human CTSB.

Key features of the study:

• This report provides an in-depth analysis of the global anti-cathepsin B market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti-cathepsin B market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals, BOC Sciences, AG Scientific, Virobay Inc., and Abcam Plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global anti-cathepsin B market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-cathepsin B market.

Detailed Segmentation:

• Global Anti-Cathepsin B Market, By Product Type :
  • Primary Antibodies
  • Proteins and Peptides
  • Lysates
• Global Anti-Cathepsin B Market, By Application :
  • Cancer
  • Traumatic Brain Injury
  • Ebola Infection
  • Fertility Treatment
  • Others
• Global Anti-Cathepsin B Market, By Technique :
  • Immunohistochemistry
  • Immunofluorescence
  • Western Blotting
  • ELISA
  • Flow Cytometry
  • Others
• Global Anti-Cathepsin B Market, By End User
  • Pharmaceutical Companies
  • Academic and Research Institutes
• Global Anti-Cathepsin B Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Merck KGaA
  • Bio-Techne
  • BioVision Inc.
  • Santa Cruz Biotechnology, Inc.
  • MedChemExpress
  • BioCat GmbH
  • ApexBio Technology
  • Cayman Chemical
  • Selleck Chemicals
  • BOC Sciences
  • AG Scientific
  • Virobay Inc.
  • Abcam Plc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Technique
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Anti-Cathepsin B Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Anti-Cathepsin B Market, By Product Type, 2018-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Primary Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Proteins and Peptides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Lysates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Anti-Cathepsin B Market, By Application, 2018-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Traumatic Brain Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Ebola Infection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Fertility Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Anti-Cathepsin B Market, By Technique, 2018-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Immunohistochemistry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Immunofluorescence
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Western Blotting
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• ELISA
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Flow Cytometry
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Others
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends

8. Global Anti-Cathepsin B Market, By End User, 2018-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Pharmaceutical Companies
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Academic and Research Institutes
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends

9. Global Anti-Cathepsin B Market, By Region, 2018-2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technique, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio-Techne
• BioVision Inc
• Santa Cruz Biotechnology, Inc
• MedChemExpress
• BioCat GmbH
• ApexBio Technology
• Cayman Chemical
• Selleck Chemicals
• BOC Sciences
• AG Scientific
• Virobay Inc
• Abcam Plc

11. Section

• Research Methodology
• About Us